03.08.2013 Views

Public Health Law Map - Beta 5 - Medical and Public Health Law Site

Public Health Law Map - Beta 5 - Medical and Public Health Law Site

Public Health Law Map - Beta 5 - Medical and Public Health Law Site

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

injectable contraceptive that lasts about 3 months as used in the United States. As<br />

with other high- maintenance implantables, medical care practitioners have a duty to<br />

keep track of patients with implantable contraceptives. They should use the same<br />

tracking system for patients with implantable contraceptives as for patients with<br />

implanted devices such as pacemakers. The patient should be given written<br />

information about the importance of follow- up care <strong>and</strong> the symptoms that should<br />

prompt an immediate call to the medical care practitioner.<br />

The patient should be contacted before the date when the contraceptive is scheduled<br />

to lose effectiveness. If the patient cannot be contacted, the physician should send a<br />

certified letter to the patient’s last known address <strong>and</strong> document that it was either<br />

received or returned. Patients with Norplant should be seen at least once a year for<br />

evaluation of potential side effects <strong>and</strong> must be seen at the end of five years to<br />

remove or replace the implants. Patients with Depo-Provera will be seen quarterly to<br />

renew the implant. When patients with either contraceptive are seen, they should be<br />

carefully checked for sexually transmitted diseases, especially HIV. Although<br />

implantable contraceptives do not facilitate pelvic infections as did IUDs, they do<br />

facilitate the spread of sexually transmitted diseases by giving the false sense that<br />

they provide protection during intercourse. <strong>Medical</strong> care practitioners should be<br />

careful to educate patients that implantable contraceptives do nothing to protect<br />

against HIV <strong>and</strong> that patients must also use condoms if they are to be avoid sexually<br />

transmitted diseases. This should be fully documented in the consent form for<br />

implantable contraceptives.<br />

4. Natural Family Planning<br />

The rhythm method has been exp<strong>and</strong>ed to include several methods of determining<br />

the time of ovulation. Although most medical care practitioners do not recognize<br />

rhythm as a medical matter, it is a form of contraception their patients may use or ask<br />

about. There are risks to this method, <strong>and</strong> these risks should be explained to patients.<br />

The most obvious risk is pregnancy. This is an effective method if used properly in<br />

selected patients, but it requires training <strong>and</strong> good record keeping. In addition, the<br />

woman must consider the social problems of abstinence. One study of the<br />

effectiveness of rhythm was discontinued after several study subjects were beaten by<br />

their husb<strong>and</strong>s for refusing intercourse. Another risk is the use of rhythm as an<br />

adjunct to barrier methods by a patient who is not trained. Many couples will not use<br />

barriers if the woman is menstruating in the mistaken belief that conception is not<br />

possible. This last risk should be discussed with patients who choose to use barrier<br />

contraceptives because it may increase the incidence of pregnancy.<br />

5. HIV Infection <strong>and</strong> AIDS<br />

HIV is already one of the most common venereal diseases. Its low infectivity has<br />

slowed its spread, but as an incurable disease with a long asymptomatic latency, its<br />

predicted equilibrium level is high. There is nothing unique about the problems<br />

522

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!